World's Best Scientists 2026 revealed!
Manal F. Abdelmalek

Manal F. Abdelmalek

D-Index & Metrics

Medicine

D-Index
91
Citations
44780
World Ranking
11546
National Ranking
5921

Manal F. Abdelmalek publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Manal F. Abdelmalek sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 327 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Manal F. Abdelmalek D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Manal F. Abdelmalek sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Manal F. Abdelmalek is affiliated with the Mayo Clinic in the United States and has a substantial body of work primarily focused on medicine with a strong emphasis on hepatology and related disciplines.

The main fields of study covered in their research include:

  • Medicine

Subfields of study include:

  • Epidemiology
  • Hepatology
  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Surgery

The scientist's primary research topics address various aspects of liver diseases and metabolism. These topics are:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Diet, Metabolism, and Disease
  • Liver Diseases and Immunity
  • Pancreatitis Pathology and Treatment
  • Diet and metabolism studies
  • Hepatitis C virus research

Manal F. Abdelmalek's recent publications reflect active involvement in defining and guiding the clinical understanding of fatty liver disease. Notable recent papers include:

  • "MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease," 2020, Gastroenterology
  • "A multisociety Delphi consensus statement on new fatty liver disease nomenclature," 2023, Hepatology
  • "A multisociety Delphi consensus statement on new fatty liver disease nomenclature," 2023, Journal of Hepatology
  • "AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease," 2023, Hepatology
  • "A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis," 2024, New England Journal of Medicine

Frequent co-authors in their collaborative work include:

  • Arun J. Sanyal
  • Rohit Loomba
  • Stephen A. Harrison
  • Anna Mae Diehl
  • Sven Francque

Publications featuring Manal F. Abdelmalek commonly appear in the following venues:

  • Journal of Hepatology
  • Hepatology
  • Gastroenterology
  • Clinical Gastroenterology and Hepatology
  • Hepatology Communications

Best Publications

  • MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.

    Mohammed Eslam;Arun J Sanyal;Jacob George

  • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    Brent A Neuschwander-Tetri;Rohit Loomba;Arun J Sanyal;Joel E Lavine

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Fructose consumption as a risk factor for non-alcoholic fatty liver disease

    Xiaosen Ouyang;Pietro Cirillo;Yuri Sautin;Shannon McCall

  • Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease.

    Manal F. Abdelmalek;Ayako Suzuki;Cynthia Guy;Aynur Unalp-Arida

  • Fructose and sugar: A major mediator of non-alcoholic fatty liver disease

    Thomas Jensen;Manal F. Abdelmalek;Shelby Sullivan;Kristen J. Nadeau

  • Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.

    Amedeo Lonardo;Fabio Nascimbeni;Stefano Ballestri;De Lisa Fairweather

  • A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis

    Scott L. Friedman;Vlad Ratziu;Stephen A. Harrison;Manal F. Abdelmalek

  • Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

    Manal F Abdelmalek;Paul Angulo;Roberta A Jorgensen;Pamela B Sylvestre

  • Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.

    Arun Sanyal;Edgar D Charles;Brent A Neuschwander-Tetri;Rohit Loomba

  • Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.

    Mohammad S. Siddiqui;Raj Vuppalanchi;Mark L. Van Natta;Erin Hallinan

  • Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

    Elizabeth M. Brunt;David E. Kleiner;Laura A. Wilson;Aynur Unalp

  • A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH.

    Sven M Francque;Pierre Bedossa;Vlad Ratziu;Quentin M Anstee

  • Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

    Mark L. Palmeri;Michael H. Wang;Ned C. Rouze;Manal F. Abdelmalek

  • Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

    Zobair M. Younossi;Rohit Loomba;Quentin M. Anstee;Mary Eugenia Rinella

  • NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

    Stephen A Harrison;Mary E Rinella;Manal F Abdelmalek;James F Trotter

  • Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.

    Susan K. Murphy;Hyuna Yang;Cynthia A. Moylan;Herbert Pang

  • No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.

    Arun J. Sanyal;Manal F. Abdelmalek;Ayako Suzuki;Oscar W. Cummings

  • Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

    Zobair M. Younossi;Rohit Loomba;Mary E. Rinella;Elisabetta Bugianesi

  • Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.

    Fasiha Kanwal;Fasiha Kanwal;Jay H. Shubrook;Leon A. Adams;Kim Pfotenhauer

Frequent Co-Authors

Anna Mae Diehl
Anna Mae Diehl Duke University
Rohit Loomba
Rohit Loomba University of California, San Diego
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
Zachary Goodman
Zachary Goodman Inova Fairfax Hospital
Brent A. Neuschwander-Tetri
Brent A. Neuschwander-Tetri Saint Louis University
Kris V. Kowdley
Kris V. Kowdley Washington State University
Naga Chalasani
Naga Chalasani Indiana University
David R. Nelson
David R. Nelson University of Tennessee Health Science Center
Joel E. Lavine
Joel E. Lavine Columbia University
Stephen H. Caldwell
Stephen H. Caldwell University of Virginia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a medical career in the USA opens the door to a variety of related online degrees and career pathways. For those interested in mental health, pursuing an msn to pmhnp online can lead to rewarding roles as a Psychiatric Mental Health Nurse Practitioner, expanding your expertise and career options.

Another popular direction is healthcare management. Comparing healthcare administration degree cost is essential, as these degrees prepare you for vital administrative roles while offering flexibility for working professionals.

Pursuing advanced leadership in healthcare? Discover the cheapest mha programs to find affordable Master’s in Healthcare Administration degrees that can lead to high-level supervisory positions in hospitals and clinics.

Nurses seeking a terminal degree can explore the best online bsn to dnp programs, which offer comprehensive clinical training with the flexibility of online learning. Each of these pathways offers unique advancement opportunities in medicine without the traditional classroom setting.

Best Scientists Citing Manal F. Abdelmalek

Trending Scientists

Recently Published Articles